Joe Rogan Is On Steroids – Gets High And Reveals What He Takes To Maintain Physique – The Overtimer

While featuring in one podcast, the UFC color commentator and podcaster Joe Rogan reveals what everybody wants to know. He reveals what he takes to maintain his physique.

Joe Rogan is a true celebrity. His podcast is so popular, that he has a worldwide reach. People around the world listen to it and eagerly await the next episodes. The reason his podcast The Joe Rogan Experience is so popular is because of the complex topics he deciphers.

Andrew Schulz is a comedian and also a fellow podcaster. He is a friend of Joe Rogan and frequently guests on his podcast. However, now, it was time for Joe to return the favor. Rogan guests on Schulzs podcast where the duo elaborates on various topics, among which the supplements and restricted substances that Rogan uses on a regular basis. Both of them get high while speaking and open up about some topics that Rogan usually doesnt speak about.

Rogan has a broad knowledge of supplements. He first mentions the Alpha Brain Black Label supplement, which is a supplement used for enhancing the cognitive function of the brain. It doesnt take much for Schulz to ask the question directly.

Joe, whats everything you take? he asks.

The big results come from testosterone replacement, so theres that, and then there are peptides that increase your bodys ability to grow hormones like growth hormones and IGF-1, Insulin-like growth factor 1 and all. Rogan replies.

Theres BPC-157, ipamorelin, thymosin. What these things do is they help your body produce the hormones that it should have when youre younger, and your body works better. he adds.

And this is not the first time that Rogan speaks about his hormone use. In past episodes of his podcast, he hints that he does take testosterone-based hormones. Now, he decides to get into details and explain more about his routines. He reveals that hormones make him feel younger, feel more powerful, and finally, they boost his strength and durability massively.

Joe Rogan believes that regular exercise and regular supplementation with multivitamins can help you greatly with your overall health and looks.

Regular exercise is the biggest thing. If theres ever one thing that someone can do to stop aging is to lift weights and dont stop. Dont lift weights for vanity. Do it because you want to keep your tissue. Age is like a little demon that is slowly robbing you of your tissue. Your ability to walk upstairs, your ability to open up jars, your ability to open the car door when its frozen. The only way to stave that off is weight lifting. he says on Schultzs podcast.

He reveals that the secret is not to lift as heavy as you can and exhaust yourself to the maximum. The thing is that you need to train regularly. No excuses, and no pauses. Regular work does the deed.

I cannot agree more on this with Rogan. Regular exercise is half of your health. The other half is a healthy diet. Once you have these two aligned success is inevitable.

Steroids are a shortcut to results in fitness and any other sport for the matter. However, while using them can have many pros, the cons are so bad, that once you know them, the chances that youll decide to take roids is close to none.

So, exercise regularly, eat healthily and everything else will fall into place.

Read the original post:

Joe Rogan Is On Steroids - Gets High And Reveals What He Takes To Maintain Physique - The Overtimer

Short Interest in Ipsen S.A. (OTCMKTS:IPSEY) Expands By 80.0% – Defense World

Ipsen S.A. (OTCMKTS:IPSEY Get Rating) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 900 shares, a growth of 80.0% from the May 15th total of 500 shares. Based on an average trading volume of 1,200 shares, the days-to-cover ratio is presently 0.8 days.

Shares of IPSEY opened at $24.14 on Monday. The stock has a 50 day moving average price of $27.14 and a two-hundred day moving average price of $26.50. Ipsen has a 52 week low of $21.71 and a 52 week high of $32.51.

The business also recently disclosed a dividend, which was paid on Thursday, June 9th. Shareholders of record on Wednesday, June 1st were issued a dividend of $0.2269 per share. This represents a yield of 0.88%. The ex-dividend date was Tuesday, May 31st.

About Ipsen (Get Rating)

Ipsen SA operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; Dysport for motor muscular disorders and medical aesthetics; NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, chronic renal failure, and GH deficiency in adults; and Increlex for growth failure in children and adolescents.

Featured Articles

Receive News & Ratings for Ipsen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ipsen and related companies with MarketBeat.com's FREE daily email newsletter.

More:

Short Interest in Ipsen S.A. (OTCMKTS:IPSEY) Expands By 80.0% - Defense World

Aeterna Zentaris Achieves Proof-of-Concept for the Treatment of NMOSD with AIM Biologicals Program – Montreal Gazette

Breadcrumb Trail Links

Author of the article:

Company advancing AIM Biologicals development program as a potential therapeutic treatment option for neuromyelitisopticaspectrum disorder (NMOSD)

Positive results presented at the 13thInternational Congress on Autoimmunity being held in Athens, Greece

Preliminary data with mouse 2D2 models of spontaneousautoimmune encephalomyelitis (EAE) indicate that mouse-adapted AIM Biologicals may reduce optic neuritis, loss of inner nuclear layer neurons and EAE symptoms

This advertisement has not loaded yet, but your article continues below.

TORONTO, ONTARIO, June 13, 2022 (GLOBE NEWSWIRE) Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (Aeterna or the Company), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced its Autoimmunity Modifying (AIM) Biologicals program has achieved pre-clinical proof-of-concept for the potential treatment of neuromyelitis optica spectrum disorder (NMOSD) (also known as Devic disease), a chronic autoimmune disorder of the brain and spinal cord dominated by inflammation of the optic nerve and spinal cord and which can be fatal in approximately 30% of patients within five years of diagnosis. These findings were presented at the 13th International Congress on Autoimmunity being held June 10-13, 2022 in Athens, Greece.

This advertisement has not loaded yet, but your article continues below.

The abstract presented at the Congress, titled Antigen presentation on MHC class Ibrelatedmolecules induces Aquaporin-4-specific regulatory T cells in PBMC and prevents experimental autoimmune encephalomyelitis in mice, was presented in a poster format and as an oral presentation by Aeternas research collaborator, Valentin Bruttel, PhD, Senior Researcher, Department of Obstetrics and Gynecology, School of Medicine, University of Wuerzburg (the University).

There remains strong unmet medical need to provide treatment options for patients diagnosed with NMOSD, a rare but potentially devastating autoimmune condition. Given the severe impact NMOSD can have on people, we are very encouraged by the proof-of concept our AIM Biologicals program has demonstrated in both in vitro and mouse models, said Dr. Klaus Paulini, Chief Executive Officer of Aeterna. We are grateful for the collaborative work being done with Dr. Bruttel, Prof. Wischhusen and their team, and we look forward to continue further developing Aeternas AIM Biologicals for the potential treatment of NMOSD.

This advertisement has not loaded yet, but your article continues below.

Aquaporin-4 (AQP-4) is the autoimmune antigen implicated in neuromyelitis optica (NMO), a demyelinating and inflammatory autoimmune disorder of the central nervous system (CNS). AIM Biologicals are based on a mechanism that is physiologically important for feto-maternal immune tolerance during pregnancy. These new biomolecules utilize the 3 domain of the human MHC class Ib molecule HLA-G to inhibit antigen-specific T cells via the human ILT-2 or the murine PIRB receptor. As part of Aeternas ongoing pre-clinical studies in collaboration with the University, researchers at the University generated fusion proteins comprising an AQP-4-derived antigenic peptide, MHC class I 1-2 antigen presenting domains, the HLA-G 3 domain and b2-microglobulin to investigate whether these novel single-chain biomolecules can induce antigen-specific tolerance towards presented AQP-4 and other neuroinflammatory peptide antigens. Various AIM Biologicals were then tested and shown to induce antigen-specific regulatory T cells (Treg) in vitro and to inhibit CD8+ driven experimental autoimmune encephalomyelitis (EAE) models and optic neuritis in 2D2 mice in vivo.

This advertisement has not loaded yet, but your article continues below.

We are very pleased with these pre-clinical proof-of-concept results which help to inform our research moving forward to define a development candidate. As demonstrated in these pre-clinical studies, we believe that Aquaporin-4-specific AIM Biologicals have the potential to provide targeted immunosuppression in NMOSD. We look forward to advancing this important program with our exclusive licensee, Aeterna, to potentially meet an indication where there remains unmet medical need, added Dr. Bruttel, who has just received the audience prize and the German innovation award at the recent German Biotechnology Days 2022.

Summary of Key Highlights

This advertisement has not loaded yet, but your article continues below.

The poster can be accessed on the Publications page of the Companys website.

About Neuromyelitis Optica Spectrum Disorder (NMOSD)

NMOSD is an antibody mediated inflammatory central nervous system (CNS) disorder that affects about one per 100,000 population per year. NMOSD, also known as Devics disease, is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve (optic neuritis) and of the spinal cord (myelitis). Typical symptoms include vision loss, muscle spasms, paraparesis, and incontinence. If left untreated, 50% of individuals with NMOSD may become wheelchair bound and blind, and 30% may have died within five years after the first attack. The water channel protein AQP4 is widely expressed in the brain, spinal cord, and optic nerves. Auto-antibodies directed against AQP4 play an important role in the pathogenesis of NMOSD.

This advertisement has not loaded yet, but your article continues below.

Currently there are only three approved medications available for the treatment of NMOSD, all with very high annual treatment costs and the risk of the patient contracting serious infections. Therefore, the Company believes there remains a strong medical need to offer new therapeutic options to the patients.

In the U.S. and Europe there are currently approximately 10,000 to 15,000 patients living with NMOSD. Of these the AQP4 antibody seropositive patients who represent about 80% of the NMOSD population are the targeted patients for a potential therapy based on the AIM Biologicals technology.

About AIM Biologicals

AIM Biologicals are targeted, highly specific autoimmunity modifying therapeutics. This platform technology utilizes a mechanism that is physiologically required for feto-maternal immune tolerance during pregnancy. Despite 50% paternal antigens, the maternal immune system tolerates a fetus, while protection against pathogens is retained. This requires selective tolerance induction against fetal antigens. During pregnancy, this goes along with an amelioration of autoimmune diseases.

This advertisement has not loaded yet, but your article continues below.

AIM Biologicals utilize a novel technique which is based on the presentation of antigens on immunosuppressive MHC class I molecules to selectively and efficiently induce antigen-specific tolerance. Based on this mechanism, targeted immunomodulatory therapeutics are designed as optimized soluble molecules and adapted to selectively induce tolerance to various autoantigens. Pre-clinical studies conducted thus far indicate that tolerance induction may be achieved via selective elimination of antigen-specific immune effector cells and via induction of antigen-specific regulatory T cells from nave T cells.

For the potential treatment of NMOSD, AIM Biologicals presenting a specific antigen derived from the water channel protein aquaporin-4 (AQP4) loaded onto a soluble immunoregulatory HLA-G protein has the potential to selectively induce immunological tolerance in the central nervous system. AIM Biologicals thus have the potential to become highly specific and effective yet not personalized treatment options for NMOSD.

This advertisement has not loaded yet, but your article continues below.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Companys lead product, macimorelin (Macrilen; Ghryvelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD), an area of significant unmet need, in collaboration with Novo Nordisk.

Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing pre-clinical pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), Parkinsons disease (PD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS; Lou Gehrigs disease). Additionally, the Company is developing an oral prophylactic bacterial vaccine against SARS-CoV-2 (COVID-19) and Chlamydiatrachomatis.

This advertisement has not loaded yet, but your article continues below.

For more information, please visit http://www.zentaris.com and connect with the Company on Twitter, LinkedIn and Facebook.

Forward-Looking Statements

This press release contains statements that may constitute forward-looking statements within the meaning of U.S. and Canadian securities legislation and regulations and such statements are made pursuant to the safe-harbor provision of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements are frequently, but not always, identified by words such as expects, anticipates, believes, intends, potential, possible, and similar expressions. Such statements, based as they are on current expectations of management, inherently involve numerous risks, uncertainties and assumptions, known and unknown, many of which are beyond our control. Forward-looking statements in this press release include, but are not limited to, those relating to: expectations regarding the potential of AIM Biologicals, to the potential to provide targeted immunosuppression, to be a highly specific and effective treatment for NMOSD and the Companys ability to conduct pre-clinical research to identify and characterize an AIM Biologicals-based development candidate for the treatment of NMOSD.

This advertisement has not loaded yet, but your article continues below.

Forward-looking statements involve known and unknown risks and uncertainties, and other factors which may cause the actual results, performance or achievements stated herein to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks and uncertainties include, among others, results from ongoing or planned pre-clinical studies of our products under development may not be successful or may not support advancing the product to human clinical trials; our ability to raise capital and obtain financing to continue our currently planned operations; our now heavy dependence on the success of Macrilen (macimorelin) and related out-licensing arrangements and the continued availability of funds and resources to successfully commercialize the product, including our heavy reliance on the success of the license agreement and the amended license agreement (collectively the Novo Amended License Agreement); the global instability due to the global pandemic of COVID-19 and the war in the Ukraine and the resulting geopolitical instability, and its unknown potential effect on our planned operations; our ability to enter into out-licensing, development, manufacturing, marketing and distribution agreements with other pharmaceutical companies and keep such agreements in effect; and our ability to continue to list our common shares on the NASDAQ. Investors should consult our quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties, including those risks discussed in our Annual Report on Form 20-F and annual information form, under the caption Risk Factors. Given the uncertainties and risk factors, readers are cautioned not to place undue reliance on these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, unless required to do so by a governmental authority or applicable law.

No securities regulatory authority has either approved or disapproved of the contents of this news release. The Toronto Stock Exchange accepts no responsibility for the adequacy or accuracy of this release.

Investor Contact:

Jenene ThomasJTC TeamT (US): +1 (833) 475-8247E: aezs@jtcir.com

This advertisement has not loaded yet, but your article continues below.

Sign up to receive daily headline news from the Montreal Gazette, a division of Postmedia Network Inc.

A welcome email is on its way. If you don't see it, please check your junk folder.

The next issue of Montreal Gazette Headline News will soon be in your inbox.

We encountered an issue signing you up. Please try again

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notificationsyou will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Original post:

Aeterna Zentaris Achieves Proof-of-Concept for the Treatment of NMOSD with AIM Biologicals Program - Montreal Gazette

Most Toxic Food in the World? Farmed Salmon. – The Epoch Times

It may even be your favorite dish to order when you eat out. Many people think its a heathy choice when they buy it or order out, but thats no longer true.

Fish are an important part of the ecosystem and the human diet. Unfortunately, overfishing has depleted many fish stocks, and the proposed solution fish farming is creating far more problems than it solves. Not only are fish farms polluting the aquatic environment and spreading disease to wild fish, farmed fish are also an inferior food source, in part by providing fewer healthy nutrients; and in part by containing more toxins, which readily accumulate in fat.

Salmon is perhaps the most prominent example of how fish farming has led us astray. Food testing reveals farmed salmon is one of the most toxic foods in the world, having more in common with junk food than health food.[1][2] Studies highlighting the seriousness of the problem date back more than a decade and include:

In 2018, researchers warned[9][10] that farmed Atlantic salmon sold in the U.S. and U.K. may also contain polybrominated diphenyl ethers (PBDEs), toxic POPs that have been restricted or banned in the U.S. and many European countries due to their toxic influence on child development.[11] As reported by The Star,[12] [A] new study by the University of Pittsburgh has found evidence of PBDEs in food fed to farmed salmon even in those in supposedly PBDE-free environments.

PBDEs are a class of chemicals that for years were used as flame retardants, and while restrictions were placed on some of the chemicals in this class in 2004, they can still be found in older products and in the environment. China, Thailand and Vietnam three areas that process significant amounts of electronic waste are known to have higher levels of PBDEs in the environment.

In more recent years, flame retardant pollution has raised serious concern, as these chemicals build up in the environment over time and are in many areas now found in both ground water and open waters.

Health risks associated with these chemicals, including PBDEs, include infertility, birth defects, neurodevelopmental delays,[13] reduced IQ,[14] hormone disruptions[15] and cancer. In fact, flame retardant chemicals have been identified as one of 17 high priority chemical groups that should be avoided to reduce breast cancer.[16]

Youre probably familiar with the saying that you are what you eat. However, a key take-home message here is that you are what your food eats. In other words, whatever the animal you eat consumed, you consume also, which means you really need to know the source of the animals feed as well. In the case of farmed fish, toxins in the fish feed and environmental concentrations of the chemicals have been identified as the two primary culprits.

According to the authors, when the fish are raised in areas with high PBDE concentrations in the water, the feed becomes a relatively minor contributor. In PBDE-free waters, on the other hand, elevated concentrations of these toxins in the feed may be high enough to end up on your plate. As noted by lead author Carla Ng, assistant professor of civil and environmental engineering at the University of Pittsburghs Swanson School of Engineering:[17]

[I]n otherwise clean and well-regulated environments, contaminated feed can be thousands of times more significant than the location of the farm for determining the PBDE content of salmon fillets The international food trade system is becoming increasingly global in nature and this applies to animal feed as well.

Fish farming operations may import their feed or feed ingredients from a number of countries, including those without advanced food safety regulations. The United States and much of Europe banned several PBDEs in 2004 because of environmental and public health concerns. PBDEs can act as endocrine disruptors and cause developmental effects. Children are particularly vulnerable.

One of the main ingredients in farmed salmon feed is fatty fish such as eel, selected for their high protein and fat content. The problem is, many toxins readily bind to fat, and the fish feed industry is using fish deemed unfit for human consumption due to elevated toxicity. As you might expect, when the fish used in fish feed contain toxic levels of pollutants, they get incorporated into the feed pellets.

One significant source of fish for farmed salmon feed is the Baltic Sea, which is well-known for its elevated pollution levels. Nine industrialized countries dump their toxic waste into this closed body of water, which has rendered many Baltic Sea fish inedible. In Sweden, fish mongers are actually required to warn patrons about the potential toxicity of Baltic fish.

According to government recommendations, you should not eat fatty fish like herring more than once a week, and if youre pregnant, fish from the Baltic should be avoided altogether. As mentioned by Ng, fish farms may also import their feed, or individual ingredients from other countries with lax regulations and significant pollution.

Some of the toxicity also stems from the manufacturing process of the feed pellets. The fatty fish are first cooked, resulting in protein meal and oil. While the oil has high levels of dioxins and PCBs, a chemical called ethoxyquin is added to the protein powder as an antioxidant, which further adds to the toxicity of the final product. Ethoxyquin, developed as a pesticide by Monsanto in the 1950s, is one of the best kept secrets of the fish food industry and one of the most toxic.

The use of ethoxyquin is strictly regulated on fruits, vegetables and in meat, but not in fish, because it was never intended for such use. Fish feed manufacturers never informed health authorities they were using this pesticide as a preservative to prevent the fats from oxidizing and going rancid, so its presence in farmed fish was never addressed.

Disturbingly, testing reveals farmed fish can contain levels of ethoxyquin that are up to 20 times higher than the level allowed in fruits, vegetables and meats.

Whats more, the effects of this chemical on human health have never been established. The only research done on ethoxyquin and human health was a thesis by Victoria Bohne, a former researcher in Norway who discovered ethoxyquin can cross the blood-brain barrier and may have carcinogenic effects. Bohne was pressured to leave her research job after attempts were made to falsify and downplay her findings.

Salmon is one fish species looked to as an indicator of environmental conditions, and salmon have become increasingly toxic. While farmed salmon is by far the worst, even wild salmon can contain unwanted pollutants. In a study[18] of salmon found in Puget Sound, researchers discovered 40 contaminants, including drugs, in the flesh of the fish.

Some of the drugs were found at levels known to interfere with growth, reproduction and behavior. No one knows exactly how this chemical cocktail affects the fish, especially as they are exposed in combination. In all, the study found 81 of 151 contaminants tested for in Puget Sound off the coast of Washington.

Aside from toxins already mentioned above, such as PCBs, PBDEs and other POPs, researchers have also found a long line of pesticides including the long-banned DDT at concerning levels in fish off the coast of California.[19] And despite the Clean Water Act, enacted nearly 40 years ago, there are areas of the U.S. where the water is so contaminated with mercury that residents are warned to refrain from eating any locally caught fish.[20]

The fish you eat may also come with a side order of microplastic;[21] in 2016 as 13 metric tons of plastic was entering the waterways every year. Once consumed, microplastic particles tend to remain in the body and accumulate, becoming increasingly concentrated in the bodies of animals higher up the food chain.

Scientists are still unsure of the effect this may have on those who eat the fish, but common sense would suggest it might not be entirely harmless, considering the fact that microplastic fibers soak up toxins like a sponge, concentrating PCBs, flame retardant chemicals, pesticides and anything else found in the water.

Evidence also suggests these microscopic particles can cross cellular membranes, causing damage and inflammation inside the cell. According to a 2016 report[22] by the British Department for Environment Food and Rural Affairs [DEFRA], microplastics have been found in a wide variety of sea creatures, from zooplankton to whales and everything in between.

According to this report, microplastics are present in seafood sold for human consumption, including mussels in North Sea mussel farms and oysters from the Atlantic.

Eating six oysters could introduce about 50 plastic microbeads into your body and, according to DEFRA, this kind of contamination may indeed pose a threat to food safety. Other studies have found one-third of the fish caught in the English Channel contain microbeads, as do 83 percent of scampi sold in the U.K.[23]

As mentioned at the beginning, farmed salmon is also nutritionally less desirable than wild, which actually ties in with its toxicity. One significant nutritional difference is the fat content. Wild salmon contains about 5 to 7 percent fat, whereas the farmed variety can contain anywhere from 14.5 to 34 percent.

This elevated fat content is a direct result of the processed high-fat feed that farmed salmon are given, and since they contain more fat, they also accumulate higher amounts of toxins. Even when raised in similarly contaminated conditions, farmed salmon will absorb more toxins than the wild fish because of this.

But farmed salmon doesnt just contain more fat overall; another nutritional travesty is its radically skewed ratios of omega-3 to omega-6 fats.[24] Half a fillet of wild Atlantic salmon contains about 3,996 milligrams (mg) of omega-3 and 341 mg of omega-6.[25] Half a fillet of farmed salmon from the Atlantic contains just a bit more omega-3 4,961 mg but an astounding 1,944 mg of omega-6;[26] more than 5.5 times more than wild salmon.

While you need both omega-3 and omega-6 fats, the ratio between the two is important and should ideally be about 1-to-1. The standard American diet is already heavily skewed toward omega-6, thanks to the prevalence of processed foods, and with farmed salmon, that unhealthy imbalance is further magnified rather than corrected.

A 2011 Norwegian report on farmed fish feed ingredients[27] titled Todays and Tomorrows Feed Ingredients in Norwegian Aquaculture talks about the negative impacts of the antinutritional factors of plant proteins and other additives in the feed.

Some of the most common ingredients in farmed fish feed include soybeans, rapeseed/canola oil, sunflower meal and oil, corn gluten meal from corn grains, wheat gluten, pulses (dry, edible seeds of field peas and faba beans), palm oil, and peanut meal and oil none of which are natural wild salmon foods.

However, as the Food and Agriculture Organization of the United Nations (FAO) explains,[28] Atlantic farmed salmon feeds can also contain animal by-products from poultry, meat meal, blood and hydrolyzed feathers. Additives such as enzymes, crustacean products (to color the salmon flesh), vitamins and selenium are also added and again, none these are ingredients that any wild salmon has ever encountered and all are about as far from a species-appropriate diet as you can get.

By 2016 more than half the fish Americans were eating came from fish farms.[29] Aquaculture promotes itself as a sustainable solution to overfishing, but when you consider it takes 1.5 to 8 kilograms (3.3 to 17.6 pounds) of wild fish to produce a single kilogram (2.2 pounds) of farmed salmon, you start to realize there are significant holes in that claim. In reality, the aquaculture industry is actually contributing heavily to the depletion of wild fish stocks rather than saving it.[30]

A salmon farm can hold upward of 2 million salmon in a relatively small amount of space. As with land-based factory farms where animals are kept in crowded conditions, fish farms are plagued with diseases that spread rapidly among the stressed fish. Sea lice, pancreas disease and infectious salmon anemia virus have spread all across Norway, yet consumers have not been informed of these fish pandemics, and sale of diseased fish continues unabated.

To stave off disease-causing pests, a number of dangerous pesticides are used, including one known to have neurotoxic effects. Workers who apply this pesticide must wear full protective clothing, yet these chemicals are dumped right into open water, where it spreads with local currents.

The pesticides used have been shown to affect fish DNA, causing genetic effects. Estimates suggest about half of all farmed cod, for example, are deformed due to genetic mutations. Whats worse, female cod that escape from farms are known to mate with wild cod, spreading the genetic mutations and deformities into the wild population.

Its become quite clear that fish farms are not a viable solution to overfishing. If anything, theyre making matters worse, destroying the marine ecosystem at a far more rapid clip. Consumers also need to be aware that some farmed salmon may also be genetically engineered (GE).

AquaBounty salmon, engineered to grow twice as fast as typical farm-raised salmon, received U.S. Food and Drug Administration approval in November 2015; it hit grocery store shelves and restaurants in 2021.[31] Originally, it had been scheduled for marketing in 2020, but was delayed due to the COVID pandemic.

Crazy enough, the FDA is not regulating Aquabountys salmon as food. It chose to review it as a drug. All GE animals, it turns out, starting with this GE salmon, will be regulated under the new animal drug provisions of the Federal Food, Drug and Cosmetic Act, because the recombinant DNA (rDNA) construct introduced into the animal meets the definition of a drug.

Interestingly, when AquaBounty announced that the GE fish was coming to market, they told The Associated Press that it would be going to restaurants and away-from-dining services where labeling as genetically engineered is not required.[32] Yet the reason the FDA gave for not requiring the fish to carry some form of GE label is that its nutritionally equivalent to conventional farm-raised Atlantic salmon.

The unnatural growth rate was achieved by inserting the DNA from two other fish, a growth-promoting gene from a Chinook salmon and a promoter gene from the eel-like ocean pout. This genetic tweaking results in fish with a chronic, continuous release of growth hormone. While a typical salmon might take up to 36 months to reach market size (and grow only in spurts during warm weather), AquaAdvantage GM salmon are ready for market in just 16 to 18 months.

The fish are being grown on land and have several other supposed safeguards in place to prevent both escape and breeding with wild populations but, in nature, nothing is foolproof. This became readily evident in 2017, when thousands of land-based Atlantic salmon escaped when the pens were broken asunder by a passing storm, creating what regulators called an environmental nightmare.[33]

So, whats the answer? Unfortunately, the vast majority of fish even when wild caught is frequently too contaminated to eat on a frequent basis. Most major waterways in the world are contaminated with mercury, heavy metals, POPs and agricultural chemicals.

This is why, as a general rule, I no longer recommend eating fish on a regular basis. There are exceptions, however. One is authentic wild-caught Alaskan salmon, the nutritional benefits of which I believe still outweigh any potential contamination. The risk of wild Alaskan salmon accumulating high amounts of mercury and other toxins is reduced because of its short life cycle, which is only about three years.

Alaskan salmon (not to be confused with Atlantic salmon) is not allowed to be farmed, and is therefore always wild-caught. Canned salmon labeled Alaskan salmon is a less expensive alternative to salmon fillets. Remember that wild salmon is quite lean, so the fat marks those white stripes you see in the meat are on the thin side.

If a fish is pale pink with wide fat marks, the salmon is likely farmed. Avoid Atlantic salmon, as salmon bearing this label are almost always farmed.

Another exception is smaller fish with short lifecycles, which also tend to be better alternatives in terms of fat content, such as sardines and anchovies. With their low contamination risk and higher nutritional value, they are a win-win alternative. Other good choices include herring and fish roe (caviar), which is full of important phospholipids that nourish your mitochondrial membranes.

Originally published Feb 2 2022 on Mercola.com

Views expressed in this article are the opinions of the author and do not necessarily reflect the views of The Epoch Times.

Read more:

Most Toxic Food in the World? Farmed Salmon. - The Epoch Times

Ask the doctor: Should my granddaughter have her adenoids removed? – Independent.ie

Question: My three-year-old granddaughter lives in another European country and has been sick a lot lately. The doctor there has suggested that she have her adenoids removed but my son is against it as he wants more information before they get it done and there is a bit of a language barrier. She is sick a lot with viruses but arent all kids? Why would a child have their adenoids out, what is the impact of it and should he go ahead or wait until she grows out of whatever it is?

Dr Grant replies: Most surgeons opt for a conservative approach or to watch and wait. In other words, they will not perform any surgery unless it is absolutely necessary or in the best interest of the child. Both tonsillectomy (removal of the tonsils) and adenoidectomy (removal of the adenoids) are among the most common surgical procedures performed in children. The decision to undergo surgery depends on the childs specific complaint, the surgeons recommendations and the guardians of the child.

Each country will vary on their guidelines and criteria, as will surgeons depending on where they currently work and where they trained in the past. The two main indications for tonsillectomy and/or adenoidectomy are upper airway obstruction and recurrent infection.

The general trend has seen a decline in the number of tonsillectomies and adenoidectomies performed for infectious indications, while the number performed for obstructive indications has increased. Expanding more on the upper airway obstruction, Obstructive Sleep Apnoea (OSA) is common in children and can lead to chronic snoring, poor sleep and in the longterm, poor overall growth and performance.

During the first few hours of sleep, children release most of the growth hormone allowing their bones to grow and if their sleep is chronically disturbed due to snoring and breath holding, it may affect overall growth. Poor sleep, we all know, leads to irritability and fatigue and adversely affects your cognitive abilities.

Long-term sleep apnoea can put additional, unnecessary strain on the cardiovascular system at night when the body is supposed to be healing and repairing. When it comes to recurrent infections, the benefits of tonsillectomy (with or without adenoidectomy) in children with recurrent throat infections (i.e. tonsillitis, pharyngitis, tonsillopharyngitis) depends on the frequency and severity of previous episodes.

For example, one criteria for surgery states the child should have +3 episodes in each of three years, +5 episodes in each of two years, or +7 episodes in one year. My own 11-year-old child had up to four severe episodes of tonsillitis per year for a number of years, and was truly miserable each time. It takes up to one week to fully recover and as a parent, it is difficult seeing your child in pain, but we held off and my child has been symptom-free for over four years now. Adenoidectomy is considered when the adenoids are enlarged (hypertrophied) and/or infected resulting in nasal obstruction, rhinosinusitis, eustachian tube dysfunction and otitis media.

Nasal obstruction may lead to chronic mouth breathing, hypo-nasal speech, and impaired olfaction (sense of smell). Severe obstruction due to adenoidal hypertrophy is an absolute indication for surgery. In summary, the decision should be made on a case-by-case basis after weighing the benefits and risks of the surgery as well as the values and preferences of the family and child.

Dr Jennifer Grant is a GP with Beacon HealthCheck

Read more from the original source:

Ask the doctor: Should my granddaughter have her adenoids removed? - Independent.ie

Hydroxyprogesterone Market Emerging Trends, Strong Application Scope, Size, Status, Analysis and Forecast to 2030 Indian Defence News – Indian…

Hydroxyprogesterone Market Report Coverage: Key Growth Factors & Challenges, Segmentation & Regional Outlook, Top Industry Trends & Opportunities, Competition Analysis, COVID-19 Impact Analysis & Projected Recovery, and Market Sizing & Forecast.

Latest launched research on Global Hydroxyprogesterone Market, it provides detailed analysis with presentable graphs, charts and tables. This report covers an in depth study of the Hydroxyprogesterone Market size, growth, and share, trends, consumption, segments, application and Forecast 2030. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Hydroxyprogesterone Market. This report has been prepared by experienced and knowledgeable market analysts and researchers. Each section of the research study is specially prepared to explore key aspects of the global Hydroxyprogesterone Market. Buyers of the report will have access to accurate PESTLE, SWOT and other types of analysis on the global Hydroxyprogesterone market. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries.

Major Key players profiled in the report include:AMAG Pharmaceuticals, Naari Ag, Mcguff Pharmaceuticals Inc, ANI Pharmaceuticals, Inc., Diosynth Bv, Mylan Institutional, Steroid Spa, Aspen Oss B.V., Antibioticos Spa, Schering Ag, Sun Pharmaceutical, Zhejiang Xianju Pharmaceutical, Symbiotec Pharmalab, Upjohn Co

Download Free Sample PDF including COVID19 Impact Analysis, full TOC, Tables and [emailprotected] https://marketstrides.com/request-sample/hydroxyprogesterone-market

Dont miss the trading opportunities on Hydroxyprogesterone Market. Talk to our analyst and gain key industry insights that will help your business grow as you create PDF sample reports.

Segmental Analysis:The report has classified the global Hydroxyprogesterone market into segments including product type and application. Every segment is evaluated based on share and growth rate. Besides, the analysts have studied the potential regions that may prove rewarding for the Hydroxyprogesterone manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, there by helping market players to gain deep insights into the overall Hydroxyprogesterone industry.

Market split by Type, can be divided into:Oral, Injection

Market split by Application, can be divided into:Hospitals, Clinics

Share your budget and Get Exclusive Discount @https://marketstrides.com/check-discount/hydroxyprogesterone-market

The authors of the report have analyzed both developing and developed regions considered for the research and analysis of the global Hydroxyprogesterone market. The regional analysis section of the report provides an extensive research study on different regional and country-wise Hydroxyprogesterone industry to help players plan effective expansion strategies.

Regions Covered in the Global Hydroxyprogesterone Market: North America (U.S., Canada) Europe (U.K., Germany, France, Italy) Asia Pacific (China, India, Japan, Singapore, Malaysia) Latin America (Brazil, Mexico) Middle East & Africa (Kuwait, Saudi Arabia Egypt)

Years Considered to Estimate the Market Size:History Year: 2019-2020Base Year: 2021Estimated Year: 2022Forecast Year: 2022-2030

What market dynamics does this report cover? The report shares key insights on:

It helps companies make strategic decisions

About Us:

Market Strides is a Global aggregator and publisher of Market intelligence development reports, equity reports, database directories, and economic reports. Our repository is diverse, spanning virtually every industrial sector and even more every category and sub-category within the industry.

Our pre-onboarding strategy for publishers is perhaps, what makes us stand out in the market space. Publishers & their market Share, reports are meticulously validated by our in-house panel of consultants, prior to a feature on our website. These in-house panel of consultants are also in charge of ensuring that our website features the most updated reports only.

Have Any Query? Ask Our Experts

Market Strides have team of professionals that assist you in many advanced industry specific trends, content and tests different strategies and implements the most productive one for the business.

For more information, Email [emailprotected]

Contact Us: +1 856 677 8909 (US)

Follow us on Social Media:

Trending Reports:https://www.digitaljournal.com/pr/colposcopes-market-analysis-2022-with-detailed-competitive-outlook-by-2026-prominent-players-cooper-surgical-edan-instruments-inchttps://marketstrides.com/report/middle-east-and-africa-growth-hormone-deficiency-therapy-markethttps://marketstrides.com/report/capacitors-for-medical-electronics-markethttps://marketstrides.com/report/text-analytics-market

Read the original:

Hydroxyprogesterone Market Emerging Trends, Strong Application Scope, Size, Status, Analysis and Forecast to 2030 Indian Defence News - Indian...

The Worldwide Human Growth Hormone Drugs Industry is Projected to Reach $4 Billion by 2026 – ResearchAndMarkets.com – Business Wire

DUBLIN--(BUSINESS WIRE)--The "Human Growth Hormone Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The global market for Human Growth Hormone Drugs estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2026, growing at a CAGR of 3.5% over the analysis period.

Subcutaneous, one of the segments analyzed in the report, is projected to grow at a 4% CAGR to reach US$2.7 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Intramuscular segment is readjusted to a revised 3.1% CAGR for the next 7-year period. This segment currently accounts for a 23.7% share of the global Human Growth Hormone Drugs market.

The U.S. Market is Estimated at $1.3 Billion in 2021, While China is Forecast to Reach $285.1 Million by 2026

The Human Growth Hormone Drugs market in the U.S. is estimated at US$1.3 Billion in the year 2021. The country currently accounts for a 40.12% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$285.1 Million in the year 2026 trailing a CAGR of 5.2% through the analysis period.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3% CAGR while Rest of European market (as defined in the study) will reach US$299.1 Million by the close of the analysis period.

Intravenous Segment to Reach $304.8 Million by 2026

In the global Intravenous segment, USA, Canada, Japan, China and Europe will drive the 2.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$231.8 Million in the year 2020 will reach a projected size of US$269.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$14.4 Million by the year 2026.

Select Competitors (Total 46 Featured) -

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/82csny

Go here to read the rest:

The Worldwide Human Growth Hormone Drugs Industry is Projected to Reach $4 Billion by 2026 - ResearchAndMarkets.com - Business Wire

Heartland Group Holdings’ (NZSE:HGH) earnings growth rate lags the 13% CAGR delivered to shareholders – Simply Wall St

Heartland Group Holdings Limited (NZSE:HGH) shareholders have seen the share price descend 14% over the month. But that doesn't change the fact that the returns over the last three years have been pleasing. After all, the share price is up a market-beating 19% in that time.

Although Heartland Group Holdings has shed NZ$95m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.

Check out our latest analysis for Heartland Group Holdings

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

During three years of share price growth, Heartland Group Holdings achieved compound earnings per share growth of 7.0% per year. We note that the 6% yearly (average) share price gain isn't too far from the EPS growth rate. Coincidence? Probably not. This suggests that sentiment and expectations have not changed drastically. Au contraire, the share price change has arguably mimicked the EPS growth.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

We know that Heartland Group Holdings has improved its bottom line lately, but is it going to grow revenue? You could check out this free report showing analyst revenue forecasts.

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Heartland Group Holdings, it has a TSR of 44% for the last 3 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return.

It's nice to see that Heartland Group Holdings shareholders have received a total shareholder return of 4.0% over the last year. And that does include the dividend. However, that falls short of the 9% TSR per annum it has made for shareholders, each year, over five years. The pessimistic view would be that be that the stock has its best days behind it, but on the other hand the price might simply be moderating while the business itself continues to execute. It's always interesting to track share price performance over the longer term. But to understand Heartland Group Holdings better, we need to consider many other factors. For instance, we've identified 3 warning signs for Heartland Group Holdings (1 is potentially serious) that you should be aware of.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on NZ exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Originally posted here:

Heartland Group Holdings' (NZSE:HGH) earnings growth rate lags the 13% CAGR delivered to shareholders - Simply Wall St

Never Take This After Age 50, Warn Pharmacists Eat This Not That – Eat This, Not That

Nutrition is crucial for healthy aging, but supplements are not as effective as food when it comes to getting the right amounts of vitamins and mineralsand some can actually be dangerous. "My motto is always 'food first,'" says Rachel Berman, R.D., Director of Nutrition for Calorie Count. "Foods found in nature are always more nutritious because our bodies are used to processing vitamins and minerals that come from natural sources." Here are five supplements you should never take after 50. Read onand to ensure your health and the health of others, don't miss these Sure Signs You've Already Had COVID.

A study from UC Davis showed that too much folic acid can aggravate complications related to vitamin B-12 deficiency, which could result in dangerous health conditions such as anemia and neurological damage. "There have been concerns that some people may be getting too much folic acid through a combination of sources, and we wanted to determine if there were reasons for those concerns," says Ralph Green, UC Davis professor of pathology and laboratory medicine. "Our results show that higher levels of folic acid could set in motion a metabolic imbalance that leads to more serious B-12 deficiency We do have to worry about folic-acid supplementation. The fact is that a lot of people are getting more of it than is good for them. If they happen to be B-12 deficient, more folic acid may actually harm them."

6254a4d1642c605c54bf1cab17d50f1e

Hormone therapy such as HGH (human growth hormone) can be dangerous, experts warn. "In this entire field, I've only encountered one board-certified endocrinologist," says Thomas Perls, M.D., associate professor of medicine and geriatrics at Boston University School of Medicine. "It's outrageous that people think they can prescribe these toxic hormone soups There is no scientific proof of this. And studies show that increasing HGH levels with drugs predisposes people to heart disease, diabetes, and cancer."

Anti-aging supplements have not been proven to work, experts warn, and most are not regulated by the FDA. "Many anti-aging doctors sell their own lines of nutraceuticals at very high prices," says Dr. Perls. "It's a profit margin that's better than what cocaine dealers get."

"We don't know if they could help, but they could be harmful," says Winifred K. Rossi, deputy director of the Division of Geriatrics and Gerontology at the National Institute on Aging.

Vitamin E is a common ingredient in brain health supplements, but too much can be dangerous.

"High doses of vitamin E supplements are associated with an increased risk of death," says dietitian Maxine Smith, RDN, LD, who recommends getting vitamin E from foods such as nuts, seeds, and dark green leafy vegetables.

Over-the-counter sexual enhancement products should be avoided, experts warn. "Products promising to enhance sexual performance have been promoted for over a century, dating back to the patent medicines of the 1800s; these products were characterized by wildly exaggerated claims and sold to the public by unscrupulous manufacturers, without evidence of safety or effectiveness," says W. Steven Pray, PhD, DPh. "Some manufacturers of impotence cures claim that their product is 'scientifically proven' to work. When a consumer sees the phrase 'clinical studies prove it works,' caution is in order, as these claims are often false. Furthermore, claims providing very high rates of success are often bogus." And to protect your life and the lives of others, don't visit any of these 35 Places You're Most Likely to Catch COVID.

Ferozan Mast

More here:

Never Take This After Age 50, Warn Pharmacists Eat This Not That - Eat This, Not That

Sleeping Tips for Runners and Why Rest Is So Important – runnersworld.com

Theres no doubt that sleep does the body goodits essential to reach the best state of physical and mental health. But oftentimes, we sacrifice sleep to fit in the demands of our everyday livesfamily, work, training, the list goes on.

While it may seem like you can make withdrawals from your sleep bank account without issue, your sleep debt (or not getting enough sleep over multiple days, as defined by the CDC) can build up over time and make it difficult for you to catch up on zzzs, leaving you feeling tired all. the. time.

So to help you catch more shut-eye, we spoke with experts to break down exactly why you need so much sleep, what it does for your performance, and how to get more quality rest.

As a runner, you probably know how important recovery is to your training (at least you should!). And your body does its best form of recovery and regeneration during your sleep cycles. Catching that shut-eye creates an optimal environment for your body to repair your muscle cells, which is what then leads to improved physical fitness over time.

A solid seven to nine hours of sleep will give your body the time it needs to go through the phases of recovery and can help prevent injury. When your body gets the sleep it needs, your immune system is also better equipped to stave off sickness. On the other hand, if you chronically miss out on rest, it can increase inflammation in the body, which can increase risk of disease, according to research.

Your eating habits can also be related to your sleep. While the research on sleep deprivation versus appetite is skewed, there is evidence that sleep is linked to your appetite hormones. These are known as leptin and ghrelin. People that have poor sleep, or not enough sleep, those appetite hormones are altered in a way that can affect metabolism and weight gain, says Ryan Soose, M.D., director of the sleep division and associate professor in the department of otolaryngology at the University of Pittsburgh.

Research also shows a link between good sleep quality and better mental health.

Soose says sleep is important for restoration and repair of nerves, muscles, and other tissues. Sleep, especially deep sleep, is when growth hormone is released, which is important for athletic training, he says. Human growth hormone (or HGH) is responsible for cell regeneration within tissues and organs all over the body. It also influences your basal metabolic function, including uptake of amino acids and protein synthesis.

Theres plenty of evidence now that chronic sleep deprivation, and reduced quality or quantity of sleep, is associated with increased injury rate, increased reports of chronic pain issues, reduced endurance, and even reduced cognition, Soose says.

Different stages of sleep bring on different types of recovery. Scott Kutscher, M.D., clinical associate professor of psychiatry and behavioral sciences at Stanford Sleep Medicine Center explains what happens during the sleep phases and why hitting them (which is what makes your sleep quality rest) is so important for runners:

You usually go through multiple sleep cycles (between four to six) while youre asleep, moving between light sleep, deeper sleep, deepest (or slow-wave) sleep, and REM sleep, with most shut-eye (about 75%) occurring in the non-REM sleep stage.

Slow wave sleep is important for physical recovery, and REM sleep is important for mental recovery, Kutscher says. In slow wave sleep, our bodys metabolism is at its lowest rate, our heart rate and blood pressure are at their lowest rates. REM sleep is typically when we consolidate our memories. This is important for racing too because running is also a mental phenomenon. You need the focus and the reaction time.

REM sleep is typically responsible for your dreams and youre usually more restless during this stage, with possible irregular muscle movements. If youre running longer races, that requires constant attention to your tasks, whether its monitoring your pace, your breath rate, thinking about your form, or mentally pushing through tough intervals. These are the areas that you can lag if youre skipping on REM sleep.

If youre getting up early for a morning run or workout, combined with not getting a full night of rest, youre potentially losing out on slow-wave sleep.

Slow wave sleep is usually referred to as the deepest sleep stage. Its when your brain waves are the slowest, and its harder to be woken up from this stage. Your growth hormone secretion is at its greatest level during this stage, too. Its the time during your sleep cycle when your body gets to work restoring and regrowing tissues, building bone and muscle and strengthening the immune system. If youre missing out on this important stage, your body will have a harder time recovering after a challenging workout or run.

Because your body is working extra hard during training, skipping out on necessary sleep stages will become even more noticeable. Even a day or two of less than seven hours of sleep can decrease reaction times significantly, Kutscher says. Your reaction time is how quickly you respond to stimulus. Whether you run sprints or like to run trails, your reaction time will improve your performance and help prevent injury and accidents.

A study published in Physiology & Behavior in 2020 suggests that just one night of sleep deprivation can affect your performance the next day. Researchers tested a group of 20 runners after they got varying amounts of sleep and had them perform two 12-minute exercises. Researchers ran one test after a night of six and a half hours of sleep, the other after a night of partial sleep (ranging from a half hour to four and a half hours).

They found that after the night of less rest, runners exhibited a higher rate of exertion, lower physical performance, and a change of heart ratenot to mention, a difference in overall mood.

As mentioned, skimping on sleep can also impair your recovery, which can make subsequent runs more difficult. It can also tank your mood and concentration, making your mental game suffer on the run.

Not only is the amount of sleep you get important for performance, but so is the quality of sleep you getand that means hitting all stages. If youre going to bed and waking up at random times, or if you cant seem to settle once your head hits the pillow, here are some tips to help you out:

Go to bed and get up at the same time every day. Make sure [those bed times and wake-up times are] giving you an adequate amount of sleep, and stick to them, Kutscher says. This sets your bodys circadian rhythm, helping you feel more tired around bedtime and more awake in the morning.

Avoid heavy meals before you hit the hay, and skip the caffeine and alcohol. They can cause stimulating effects, which make it harder to fall asleep, and they can mess with your sleep quality.

One study published in Sleep Medicine Reviews in 2021 also shows that there may be a link between diet and sleep quality. Consumption of healthy foods (think fruits and veggies) helps to promote better sleep, while high intake of processed foods and sugar-rich items may trigger sleep problems.

A study published in Mindfulness in 2021 suggests that mind-body activities, like practicing mindfulness, might improve sleep quality over time in people with chronic pain. Consider incorporating mindful exercises like meditation, yoga, or breathing techniques into your daily routine to boost relaxation and help you catch more shut-eye.

Soose recommends creating a space that is cool, comfortable, and dark. Athletes are often in hotels and different environments that physically make it hard to get the right amount of sleep. The more you can control that bedroom or sleep environment, the better, he says.

Just being a runner should pay off in better sleep, as exercise can improve your rest. Research shows physical activity, particularly weight training, promotes better sleep habits. Exercising earlier in the day may help you fall asleep easier at night.

Winding down before bed, sans your devices, can positively influence your sleep hygiene. Thats because the light on your phone, TV, or tablet can mimic sunlight and then mess with your sleep-wake cycle, according to research. Try to ditch screens 30 to 60 minutes before hitting the pillow.

It can be challenging to switch up your sleep schedule and get into a healthier routinesome habits may be easier to kick than others. One of the important factors is follow-through: If youre noticing more lethargy during your runs or your body isnt recovering as fast after a few hard workouts, your sleep routine may be the culprit. Start with one small change, like going to bed 20 minutes earlier, and take it from there.

Lastly, if you find that your sleep difficulties dont improve after testing out new practices, consult your physician or a specialist. Sleep disorders like apnea and restless legs syndrome could be at play. A professional can help you create a plan for quality sleep so that youre well-rested and ready to hit the ground running.

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

See the article here:

Sleeping Tips for Runners and Why Rest Is So Important - runnersworld.com